Document is current

Article History

Received: 23 April 2023

Accepted: 25 July 2023

First Online: 15 September 2023

Authors’ relationships and activities

: BMB received lecture or advisory board fees from Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Mundipharma, Novartis, Novo Nordisk and Sanofi. MLM received lecture fees or advisory board fees from Eli Lilly, MSD, Novo Nordisk, SLA-Pharma and Servier. AA received research grants and lecture or advisory board fees from MSD, AstraZeneca, Novartis, Boehringer Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier and Takeda. GPF received grants, honoraria or lecture fees from Abbott, AstraZeneca, Boehringer, Lilly, MSD, Novo Nordisk, Sanofi, Servier and Takeda. The other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.

: BMB contributed to study design, data research, analysis and interpretation, and manuscript writing. MLM contributed to study design, data research, analysis and interpretation, and manuscript revision. MM and RC contributed to data research, analysis and interpretation, and manuscript revision. AA contributed to study design, data interpretation and manuscript revision. GPF contributed to study design, data research, analysis and interpretation, and manuscript writing. All authors approved the final version of the manuscript. GPF is the guarantor of this study and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.